A brief introduction of the molecule, antibody, protein or cell used as therapy. A short description of the pathophysiology


A brief introduction of the molecule, antibody, protein or cell used as therapy.
A short description of the pathophysiology of the disease for which this treatment is approved.
The mechanism of action, any clinical trial outcome, and adverse reactions.
Supporting scientific literature. The antibody for the presentation is Tefibazumab with a two page paper and PowerPoint.